Balanced news tone
News Sentiment
LMRI sentiment intelligence
Lumexa Imaging Holdings, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-3.5% over one week, +24.5% over four weeks, trend inactive, and near fair-value range.
Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 13:55
- Source
- Market source
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Jul 2026 09:24
- Source
- DirectorsTalk Interviews
UG Outperforms Industry in 6 Months: Buy, Sell or Hold the Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 14:10
- Source
- TradingView
Lumexa Imaging (LMRI) Stock Forum and Discussion
This article provides a stock forum and discussion for Lumexa Imaging (LMRI). It is a placeholder indicating that a detailed discussion will follow regarding this company's stock.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 17:10
- Source
- Moomoo
Lumexa Imaging Refinances Debt
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 01 Jul 2026 10:29
- Source
- MT Newswires
Lumexa Imaging (LMRI) amends $823M term loan and $250M revolving credit deal
Lumexa Imaging Holdings, Inc. (LMRI) has amended its primary debt facilities, establishing a new secured term loan of approximately $823 million and a secured revolving credit facility of $250 million. These facilities bear interest at SOFR plus 2.50% or Prime Rate plus 1.50% and
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 01 Jul 2026 02:09
- Source
- Stock Titan
Lumexa Imaging Amends Credit Pact, Secures $823 Million Term Loan and $250 Million Revolver
Lumexa Imaging (LMRI) has amended its Credit Agreement, securing an $823 million secured term loan and a $250 million secured revolving credit facility. These facilities are intended to refinance existing debt and improve the company's liquidity position. The term loan matures in
- Tone
- Positive 75/100
- Event
- Balance sheet
- Published
- 30 Jun 2026 21:09
- Source
- TradingView
Lumexa Imaging Holdings - Subsidiaries Amend Credit Agreement With Barclays Bank On June 30, 2026 - SEC Filing
Lumexa Imaging Holdings announced that its subsidiaries have amended a credit agreement with Barclays Bank. This amendment took place on June 30, 2026, and was disclosed in an SEC filing. The article provides this information concisely, indicating a financial adjustment for the c
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 30 Jun 2026 21:09
- Source
- TradingView
Lumexa Imaging Holdings, Inc.(NasdaqGS:LMRI) dropped from Russell 2500 Growth Benchmark
Lumexa Imaging Holdings, Inc. (NasdaqGS:LMRI) has been removed from the Russell 2500 Growth Benchmark, a decision announced on June 29, 2026. This exclusion is part of several benchmark drops for the company on the same day, including Russell Small Cap Comp Growth and Russell 300
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 29 Jun 2026 14:40
- Source
- marketscreener.com
Lumexa Imaging Holdings, Inc.(NasdaqGS:LMRI) dropped from Russell 3000 Growth Benchmark
Lumexa Imaging Holdings, Inc. (NasdaqGS:LMRI), a national provider of diagnostic imaging services, has been removed from the Russell 3000 Growth Benchmark. The company's stock experienced a 2.75% increase on July 1st, alongside news of significant debt refinancing and a new credi
- Tone
- Negative 19/100
- Event
- Balance sheet
- Published
- 29 Jun 2026 02:18
- Source
- www.marketscreener.com
Price to book forward of Lumexa Imaging Holdings, Inc. – NASDAQ:LMRI
The article focuses on the "Price to book forward" financial metric for Lumexa Imaging Holdings, Inc., traded on NASDAQ under the symbol LMRI. It indicates the stock market is currently closed with no trades. The content primarily lists navigation and structural elements of the f
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 14:09
- Source
- TradingView
LMRI Forecast — Price Target — Prediction for 2027
This article provides a forecast for Lumexa Imaging Holdings, Inc. (LMRI) stock, including analyst price targets and predictions for 2027. It details the company's current stock price, past performance, market capitalization, earnings, revenue, and other financial metrics. The ar
- Tone
- Positive 65/100
- Event
- Earnings
- Published
- 26 Jun 2026 13:42
- Source
- TradingView
Lumexa Imaging Holdings, Inc. Actuals & Estimates (NASDAQ:LMRI)
This article provides an overview of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI), focusing on its financial actuals, analyst estimates, and stock performance. It includes details such as its current stock price, market capitalization, volatility, and future earnings and revenue e
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 06:10
- Source
- TradingView
Price to sales forward of Lumexa Imaging Holdings, Inc. – NASDAQ:LMRI
This page from TradingView provides financial information for Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI), specifically focusing on its price-to-sales forward metric. The content indicates that while the market is closed, detailed financial data, news, and community insights are
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 01:10
- Source
- TradingView
Price to earnings forward of Lumexa Imaging Holdings, Inc. – NASDAQ:LMRI
The article provides a title hinting at the price-to-earnings forward ratio for Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI), but the content itself serves as a placeholder or an empty page from TradingView, displaying navigation, market data sources, and copyright information wi
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 16:40
- Source
- TradingView
Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 13:55
- Source
- Zacks
Should I buy Lumexa Imaging Holdings, Inc. (LMRI)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Zacks Investment Research
This Undervalued Medical-Devices Stock Is Poised for a Rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Barron's
Lumexa Imaging Holdings Ord Shs (LMRI) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Lumexa Imaging Holdings Ord Shs (LMRI), detailing analyst ratings, target prices, and projected EPS and revenue figures. Eight analysts currently rate LMRI as a "Strong Buy," with a target price indicating a potential 90.11% upside.
- Tone
- Positive 68/100
- Event
- Earnings
- Published
- 18 Jun 2026 03:40
- Source
- TradingKey
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
Loss-Making Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Set To Breakeven
This article analyzes Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) and its path to profitability. Analysts predict the company will breakeven in 2026, with an expectation of rapid revenue growth in the near future. While the company is currently loss-making, its strong balance she
- Tone
- Positive 69/100
- Event
- Earnings
- Published
- 14 Jun 2026 20:39
- Source
- 富途牛牛
Lumexa Imaging (NASDAQ: LMRI) investors reelect directors and ratify PwC
Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) announced the results of its 2026 Annual Meeting of Stockholders. Shareholders reelected three Class I directors—Lee Cooper, Brian Regan, and Caitlin Zulla—to serve until the 2029 annual meeting. Additionally, PricewaterhouseCoopers LL
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jun 2026 21:10
- Source
- Stock Titan
Lumexa Imaging Holdings (LMRI) director receives 19,358 restricted stock units
Bridget E. Karlin, a director at Lumexa Imaging Holdings, Inc. (LMRI), was granted 19,358 restricted stock units (RSUs) as part of her stock-based compensation. These RSUs, which represent one share of common stock each, were awarded at no cash cost and will vest on the earlier o
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 12 Jun 2026 20:39
- Source
- Stock Titan
Director at Lumexa Imaging (LMRI) awarded 19,358 RSUs
Glenn A. Eisenberg, a director at Lumexa Imaging Holdings, Inc. (LMRI), was granted 19,358 restricted stock units (RSUs) on June 10, 2026. These RSUs will vest on the earlier of the one-year anniversary of the grant date or the company's next annual meeting, contingent on his con
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 20:39
- Source
- Stock Titan
[Form 4] Lumexa Imaging Holdings, Inc. Insider Trading Activity
A Form 4 filing indicates that Robert Louis Mittl Jr., a director at Lumexa Imaging Holdings, Inc. (LMRI), was granted 19,358 restricted stock units (RSUs). These RSUs vest on the earlier of one year from the grant date or the next annual meeting, provided he continues his servic
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 20:39
- Source
- Stock Titan
Director Joseph Molly awarded 19,358 RSUs at Lumexa Imaging (LMRI)
Lumexa Imaging director Joseph Molly was granted 19,358 Restricted Stock Units (RSUs) at a price of $0.00 per share, increasing his direct holdings to 46,385 shares. These RSUs will vest on the earlier of the one-year anniversary of the grant date or the next annual stockholders'
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 11:40
- Source
- Stock Titan
Breakeven Is Near for Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)
Analyst forecasts suggest that Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) is nearing profitability, with expectations of breaking even within the next year. The company, which posted a loss of US$38 million in the latest trailing-twelve-month period, is projected to generate pos
- Tone
- Positive 64/100
- Event
- Analyst action
- Published
- 11 Jun 2026 11:09
- Source
- Market source
Lumexa Imaging (LMRI) director Matthew Lungren receives 19,358 RSU grant
Matthew Lungren, a director at Lumexa Imaging Holdings, Inc. (LMRI), has been granted 19,358 Restricted Stock Units (RSUs). This grant, valued at $0.00 per share as it is compensation-based, will vest on the earlier of one year from the grant date or the next annual stockholders'
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 23:11
- Source
- Stock Titan
Lumexa Imaging (LMRI) director awarded 19,358 RSUs and reports 30,000 trust-held shares
Lumexa Imaging (LMRI) director Cooper Henry Lee was granted 19,358 Restricted Stock Units (RSUs) as compensation, which vest on the earlier of one year or the next annual stockholder meeting, contingent on continued service. Following this grant, he directly holds 19,358 shares a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 23:11
- Source
- Stock Titan